NLRC4 and metabolic dysfunction-associated steatohepatitis: In a mouse model of non-alcoholic steatohepatitis (NASH), NLRC4 knockout promoted the growth and recurrence of liver metastases of colorectal cancer, but significantly restricted hepatic tumorigenesis.